Related Experiment Video
Updated: Jun 6, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
Sugar Low When NPO? Patient Variables Associated With Pediatric Preoperative Hypoglycemia
Gretchen Rogers1, Jenny Beitz1, Shara Griffin1
1Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Summary
Pediatric preoperative hypoglycemia may be linked to age, anesthesia risk, and prior diabetes history. Further research is needed to confirm these risk factors in children.
Area of Science:
- Pediatric Anesthesiology
- Clinical Research
- Patient Safety
Background:
- Preoperative hypoglycemia in pediatric patients can lead to adverse outcomes.
- Identifying risk factors is crucial for prevention and management.
Purpose of the Study:
- To identify demographic and patient-specific factors associated with preoperative hypoglycemia in pediatric surgical patients.
- To compare characteristics of hypoglycemic pediatric patients with the general surgical population.
Main Methods:
- Retrospective chart review of pediatric patients treated for preoperative hypoglycemia.
- Evaluation of 10 variables including age, gender, weight, fasting duration, ASA status, surgical service, bowel preparation, complications, and diabetes history.
- Comparison with the hospital's general surgical population where data were available.
Main Results:
- No significant differences in race, gender, or intraoperative complications between hypoglycemic and general surgical populations.
- Significant differences observed in age, American Society of Anesthesiology (ASA) status, history of diabetes/hypoglycemia, procedure type (GI/pulmonary), and time of hypoglycemic event.
- Trends identified for body weight, preoperative bowel cleanout, and fasting duration in the hypoglycemia group.
Conclusions:
- Age, ASA status, diabetes history, specific procedures, and timing of events are potential risk factors for pediatric preoperative hypoglycemia.
- The retrospective nature limits definitive conclusions; further research is necessary to validate these findings.
- Additional research is required to confirm identified risk factors and explore other potential contributors to pediatric preoperative hypoglycemia.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
SBAR II: Application of SBAR
4.3K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.3K
Oral Hypoglycemic Agents: Glinides
141
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
141
Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145
Pathophysiology of Diabetes
868
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
868
Parenteral Anesthetics: Overview
100
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
100

